Silk Road Medical, Inc (SILK)
NASDAQ: SILK · IEX Real-Time Price · USD
18.90
-1.26 (-6.25%)
At close: May 2, 2024, 4:00 PM
19.32
+0.42 (2.22%)
After-hours: May 2, 2024, 6:38 PM EDT
Silk Road Medical Revenue
In the year 2023, Silk Road Medical had annual revenue of $177.13M with 27.77% growth. Revenue in the quarter ending December 31, 2023 was $47.27M with 17.97% year-over-year growth.
Revenue (ttm)
$177.13M
Revenue Growth
+27.77%
P/S Ratio
4.21
Revenue / Employee
$373,700
Employees
474
Market Cap
745.45M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 177.13M | 38.50M | 27.77% |
Dec 31, 2022 | 138.64M | 37.16M | 36.62% |
Dec 31, 2021 | 101.48M | 26.25M | 34.89% |
Dec 31, 2020 | 75.23M | 11.87M | 18.74% |
Dec 31, 2019 | 63.35M | 28.80M | 83.33% |
Dec 31, 2018 | 34.56M | 20.30M | 142.37% |
Dec 31, 2017 | 14.26M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pediatrix Medical Group | 1.99B |
HealthStream | 282.88M |
Canopy Growth | 248.53M |
Paragon 28 | 216.39M |
Aurinia Pharmaceuticals | 175.51M |
Atrion | 169.33M |
REGENXBIO | 90.24M |
PureTech Health | 3.33M |
SILK News
- 2 days ago - Silk Road Medical Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 9 days ago - Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference - GlobeNewsWire
- 23 days ago - Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024 - GlobeNewsWire
- 4 weeks ago - Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS - GlobeNewsWire
- 2 months ago - Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System - GlobeNewsWire
- 2 months ago - Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook - GlobeNewsWire
- 3 months ago - Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 - GlobeNewsWire
- 4 months ago - Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire